Hospital
Howard University Hospital Corp
Howard University Hospital Corp was paid $98.83M by Medicaid between Jan 2018 and Dec 2024, across 378 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.
33Billing provider infoHOWARD UNIVERSITY HOSPITAL CORP
WASHINGTON, DC 20060
WASHINGTON, DC 20060
33aNPI1487740957assigned 10/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$98.83M
24GClaims1,475,583
24DCodes billed378
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 236,065 | $10.44M | |
| 2019 | 254,380 | $12.97M | |
| 2020 | 214,876 | $10.57M | |
| 2021 | 269,240 | $13.72M | |
| 2022 | 242,522 | $19.82M | |
| 2023 | 162,460 | $18.02M | |
| 2024incomplete | 96,040 | $13.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 48,324 | 43,177 | $11.07M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.9% | 39,779 | 35,696 | $8.82M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.0% | 34,679 | 30,519 | $6.95M |
| 70450 | Computed tomography, head or brain; without contrast material | 6.2% | 17,782 | 16,463 | $6.14M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 30,525 | 27,642 | $5.61M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.9% | 24,307 | 9,238 | $4.88M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 3.8% | 2,910 | 2,646 | $3.75M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.0% | 4,526 | 4,315 | $2.97M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2.7% | 4,010 | 3,843 | $2.66M |
| 59025 | Fetal non-stress test | 2.4% | 8,121 | 4,480 | $2.39M |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.4% | 19,389 | 7,603 | $2.37M |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 2.1% | 2,138 | 2,066 | $2.07M |
366 more codes
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.9% | 2,046 | $1.84M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 6,454 | $1.77M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 5,298 | $1.69M |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 3,395 | $1.66M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 3,545 | $1.54M |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.5% | 7,838 | $1.46M |
| G0378 | Hospital observation service, per hour | 1.3% | 7,778 | $1.24M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.2% | 10,288 | $1.21M |
| 97010 | 1.2% | 13,960 | $1.18M | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 5,896 | $1.10M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.1% | 4,604 | $1.08M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.0% | 7,266 | $1.02M |
| 97162 | 1.0% | 3,749 | $1.01M | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.0% | 1,128 | $997K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,865 | $702K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 19,390 | $675K |
| 76641 | <1% | 3,296 | $642K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,082 | $622K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 5,209 | $618K |
| 97164 | <1% | 2,586 | $611K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 6,018 | $595K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 8,655 | $569K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 23,156 | $567K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 5,240 | $546K |
| 95811 | <1% | 678 | $540K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,417 | $484K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,738 | $463K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 3,129 | $438K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 3,344 | $389K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13,689 | $383K |
| 93970 | <1% | 2,023 | $375K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 6,301 | $368K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,600 | $363K |
| 93971 | <1% | 2,485 | $358K | |
| 76770 | <1% | 1,844 | $349K | |
| 96367 | <1% | 3,769 | $345K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,222 | $337K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14,460 | $314K |
| 76801 | <1% | 3,698 | $301K | |
| 94060 | <1% | 2,924 | $289K | |
| 71250 | <1% | 3,519 | $279K | |
| 73564 | <1% | 6,884 | $274K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,327 | $261K |
| 73630 | <1% | 6,775 | $258K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,808 | $258K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 7,483 | $249K |
| 76536 | <1% | 1,529 | $249K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 60,166 | $248K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 7,423 | $235K |
| 76830 | Ultrasound, transvaginal | <1% | 4,001 | $216K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,357 | $194K |
| 97163 | <1% | 628 | $183K | |
| 96415 | <1% | 811 | $179K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,528 | $169K |
| 70486 | <1% | 5,173 | $162K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 29,340 | $159K |
| 12001 | <1% | 543 | $159K | |
| 72131 | <1% | 2,894 | $148K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,300 | $144K |
| 72110 | <1% | 3,439 | $129K | |
| 90714 | <1% | 3,796 | $122K | |
| 80053 | Comprehensive metabolic panel | <1% | 31,053 | $119K |
| 74178 | <1% | 456 | $118K | |
| 73130 | <1% | 5,600 | $117K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 1,412 | $116K |
| 73610 | <1% | 4,700 | $112K | |
| 77066 | Tomosynthesis, mammo | <1% | 1,883 | $111K |
| 73030 | <1% | 4,779 | $107K | |
| 97161 | <1% | 269 | $99K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 281 | $99K |
| 92550 | <1% | 995 | $94K | |
| 92587 | <1% | 560 | $91K | |
| 12002 | <1% | 328 | $85K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 1,882 | $78K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 2,799 | $78K |
| 70491 | <1% | 277 | $76K | |
| 76813 | <1% | 912 | $68K | |
| 73562 | <1% | 1,307 | $68K | |
| 71045 | Radiologic examination, chest; single view | <1% | 15,779 | $65K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,126 | $63K |
| 77065 | Tomosynthesis, mammo | <1% | 1,318 | $63K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 476 | $60K |
| 10060 | <1% | 191 | $59K | |
| 94727 | <1% | 1,596 | $54K | |
| 73502 | <1% | 2,093 | $53K | |
| 73590 | <1% | 2,986 | $52K | |
| 12011 | <1% | 200 | $52K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 186 | $50K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 282 | $49K |
| 80047 | <1% | 7,946 | $47K | |
| 77081 | <1% | 811 | $46K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,237 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 88,800 | $43K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 199 | $43K |
| 78580 | <1% | 26 | $43K | |
| 73110 | <1% | 3,213 | $41K | |
| 84484 | <1% | 23,268 | $40K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 2,586 | $37K |
| 83880 | <1% | 5,118 | $36K | |
| 76882 | <1% | 201 | $36K | |
| 99219 | <1% | 1,982 | $34K | |
| 87040 | <1% | 2,721 | $33K | |
| 78451 | <1% | 155 | $32K | |
| G0390 | Trauma response team associated with hospital critical care service | <1% | 2,905 | $32K |
| 93976 | <1% | 211 | $31K | |
| D0330 | Panoramic radiographic image | <1% | 499 | $30K |
| 97116 | <1% | 453 | $30K | |
| 87400 | <1% | 1,803 | $28K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 187 | $28K |
| 94729 | <1% | 1,557 | $26K | |
| 97014 | <1% | 884 | $24K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 88 | $24K |
| 95813 | <1% | 31 | $23K | |
| 96040 | <1% | 119 | $23K | |
| 71271 | <1% | 164 | $21K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 88 | $20K |
| 83605 | <1% | 11,996 | $20K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 78 | $19K |
| 72052 | <1% | 407 | $19K | |
| D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | <1% | 120 | $19K |
| 76870 | <1% | 253 | $18K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 53 | $17K |
| D9310 | <1% | 176 | $17K | |
| 73090 | <1% | 1,832 | $16K | |
| 83874 | <1% | 4,842 | $16K | |
| 97032 | <1% | 102 | $15K | |
| 73560 | <1% | 571 | $15K | |
| 99205 | Prolong outpt/office vis | <1% | 68 | $15K |
| 85378 | <1% | 2,774 | $14K | |
| D9222 | <1% | 134 | $14K | |
| 73080 | <1% | 1,196 | $13K | |
| 83735 | <1% | 12,514 | $13K | |
| 80061 | Lipid panel | <1% | 3,005 | $12K |
| 73551 | <1% | 863 | $12K | |
| 82728 | <1% | 2,127 | $11K | |
| 94762 | <1% | 3,069 | $10K | |
| 76642 | <1% | 46 | $10K | |
| 95819 | <1% | 54 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,963 | $9K |
| 45384 | <1% | 37 | $9K | |
| 73140 | <1% | 393 | $9K | |
| 97166 | <1% | 25 | $8K | |
| 73521 | <1% | 156 | $8K | |
| 97016 | <1% | 59 | $8K | |
| 97018 | <1% | 102 | $8K | |
| 76820 | <1% | 82 | $8K | |
| 88341 | <1% | 594 | $7K | |
| 88307 | <1% | 278 | $7K | |
| 85730 | <1% | 15,821 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 674 | $7K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,772 | $7K |
| 90715 | <1% | 272 | $7K | |
| 82553 | <1% | 5,469 | $7K | |
| 72100 | <1% | 210 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,949 | $6K |
| 96523 | <1% | 78 | $6K | |
| 86900 | <1% | 6,243 | $6K | |
| 72128 | <1% | 1,803 | $6K | |
| 73060 | <1% | 957 | $6K | |
| 72040 | <1% | 179 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 8,571 | $6K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 14 | $5K |
| 99220 | <1% | 479 | $5K | |
| 92557 | <1% | 202 | $5K | |
| 77336 | <1% | 73 | $5K | |
| 82607 | <1% | 1,511 | $5K | |
| 76818 | <1% | 44 | $5K | |
| 82948 | <1% | 27,210 | $5K | |
| 73620 | <1% | 274 | $5K | |
| 82248 | <1% | 6,867 | $5K | |
| 86923 | <1% | 69 | $5K | |
| 86850 | <1% | 6,090 | $5K | |
| 84100 | <1% | 9,252 | $5K | |
| 99201 | <1% | 30 | $4K | |
| 85014 | <1% | 8,394 | $4K | |
| 77014 | <1% | 104 | $4K | |
| 81003 | <1% | 22,742 | $4K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 22 | $4K |
| 85610 | <1% | 15,718 | $4K | |
| J1815 | Injection, insulin, per 5 units | <1% | 2,978 | $4K |
| 81001 | <1% | 15,203 | $4K | |
| 70490 | <1% | 15 | $4K | |
| 88342 | <1% | 4,635 | $3K | |
| 85045 | <1% | 4,146 | $3K | |
| 72170 | <1% | 3,007 | $3K | |
| 93226 | <1% | 77 | $3K | |
| 84702 | <1% | 7,004 | $3K | |
| 95816 | <1% | 12 | $3K | |
| 83615 | <1% | 2,330 | $3K | |
| 97802 | <1% | 30 | $3K | |
| 41800 | <1% | 15 | $3K | |
| 86901 | <1% | 6,236 | $3K | |
| 76937 | <1% | 60 | $3K | |
| 73221 | <1% | 14 | $3K | |
| 83690 | <1% | 14,980 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,094 | $3K |
| 84703 | <1% | 7,152 | $2K | |
| 72070 | <1% | 139 | $2K | |
| 82550 | <1% | 9,716 | $2K | |
| 73600 | <1% | 198 | $2K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 103 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,206 | $2K |
| 93017 | <1% | 13 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,620 | $2K |
| 74019 | <1% | 110 | $2K | |
| 76802 | <1% | 40 | $2K | |
| 82150 | <1% | 10,452 | $2K | |
| 82805 | <1% | 1,285 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,975 | $2K |
| 93225 | <1% | 77 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 138 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 856 | $1K |
| 99218 | <1% | 205 | $1K | |
| 86592 | <1% | 1,358 | $1K | |
| 84075 | <1% | 5,399 | $1K | |
| 81025 | <1% | 7,586 | $1K | |
| 80185 | <1% | 158 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 279 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 16,412 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 37,214 | $1K |
| 82533 | <1% | 36 | $1K | |
| 86140 | <1% | 1,314 | $990.44 | |
| 86703 | <1% | 1,126 | $963.46 | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 13 | $962.50 |
| 85651 | <1% | 1,786 | $926.69 | |
| 74174 | <1% | 16 | $907.22 | |
| 74018 | <1% | 77 | $894.96 | |
| 77080 | <1% | 19 | $845.44 | |
| 82010 | <1% | 2,547 | $835.63 | |
| 87070 | <1% | 633 | $828.45 | |
| 71101 | <1% | 180 | $785.93 | |
| 84145 | <1% | 168 | $753.92 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,675 | $703.43 |
| 85007 | <1% | 3,711 | $700.22 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,771 | $696.57 |
| 93296 | <1% | 12 | $680.73 | |
| 84550 | <1% | 1,206 | $656.28 | |
| 87081 | <1% | 270 | $635.26 | |
| 84439 | <1% | 354 | $598.77 | |
| 82040 | <1% | 5,469 | $523.13 | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 363 | $490.40 |
| 81002 | <1% | 11,596 | $455.62 | |
| C1758 | Catheter, ureteral | <1% | 692 | $437.14 |
| 83540 | <1% | 669 | $427.65 | |
| C1780 | Lens, intraocular (new technology) | <1% | 2,424 | $425.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 20,263 | $424.88 |
| J3490 | Unclassified drugs | <1% | 6,841 | $420.46 |
| 83021 | <1% | 73 | $402.77 | |
| 82043 | <1% | 205 | $384.69 | |
| 80177 | <1% | 28 | $379.64 | |
| C1769 | Guide wire | <1% | 606 | $372.68 |
| 87186 | <1% | 278 | $364.65 | |
| 94760 | <1% | 3,156 | $359.82 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 631 | $339.18 |
| 82570 | <1% | 438 | $332.23 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 14,123 | $329.64 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 4,670 | $305.25 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,978 | $299.72 |
| 84153 | <1% | 129 | $289.90 | |
| 82746 | <1% | 93 | $278.20 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,921 | $268.50 |
| 36600 | <1% | 81 | $268.28 | |
| 84466 | <1% | 437 | $260.24 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 1,113 | $254.23 |
| 82247 | <1% | 5,467 | $246.39 | |
| 84156 | <1% | 368 | $216.28 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 11,014 | $207.54 |
| 83010 | <1% | 41 | $196.38 | |
| 84450 | <1% | 5,425 | $189.73 | |
| 84460 | <1% | 5,423 | $178.86 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,953 | $163.04 |
| 85018 | <1% | 1,090 | $162.82 | |
| 88304 | <1% | 132 | $149.72 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 7,925 | $146.80 |
| 82330 | <1% | 851 | $138.89 | |
| 85027 | <1% | 198 | $138.22 | |
| 80164 | <1% | 15 | $137.61 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,442 | $121.05 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 88 | $105.09 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,083 | $83.13 |
| 82747 | <1% | 102 | $78.18 | |
| 97124 | <1% | 34 | $76.91 | |
| C1729 | Catheter, drainage | <1% | 203 | $73.06 |
| 84480 | <1% | 61 | $69.89 | |
| 76001 | <1% | 76 | $64.62 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 350 | $61.97 |
| 82947 | <1% | 841 | $55.33 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 10,188 | $54.64 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 17,236 | $46.94 |
| 80051 | <1% | 775 | $35.37 | |
| 73552 | <1% | 13 | $29.79 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 2,806 | $29.15 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,585 | $28.47 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 3,285 | $28.13 |
| 84132 | <1% | 731 | $24.80 | |
| L0172 | Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf | <1% | 571 | $24.64 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 569 | $23.46 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,011 | $22.88 |
| 84520 | <1% | 828 | $21.80 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,146 | $19.76 |
| J7110 | Infusion, dextran 75, 500 ml | <1% | 1,209 | $18.92 |
| 87340 | <1% | 165 | $17.68 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 3,075 | $15.74 |
| 82435 | <1% | 36 | $15.20 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 4,933 | $13.61 |
| 82565 | <1% | 784 | $11.39 | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 873 | $10.46 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 1,361 | $10.27 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,858 | $9.51 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | <1% | 168 | $9.29 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 846 | $9.00 |
| 84295 | <1% | 715 | $7.81 | |
| 86706 | <1% | 45 | $7.25 | |
| 85041 | <1% | 15 | $5.83 | |
| 87071 | <1% | 12 | $5.61 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 137 | $5.38 |
| 84436 | <1% | 14 | $4.43 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 4,347 | $1.44 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,535 | $0.47 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 814 | $0.35 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | <1% | 330 | $0.24 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 534 | $0.01 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 57 | $0.01 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 146 | $0.01 |
| 0250 | 0% | 2,377 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 206 | $0.00 |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | 0% | 709 | $0.00 |
| 0270 | 0% | 1,546 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 339 | $0.00 |
| 0258 | 0% | 379 | $0.00 | |
| 0710 | 0% | 313 | $0.00 | |
| 96376 | 0% | 361 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 136 | $0.00 |
| C1893 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away | 0% | 123 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 43 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 0% | 51 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 41 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 38 | $0.00 |
| A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | 0% | 12 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 17 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 16 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 13 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 28 | $0.00 |
| 0370 | 0% | 289 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 16 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 14 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 16 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,597 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 905 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 896 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 949 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 306 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 112 | $0.00 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 13 | $0.00 |
| 88312 | 0% | 12 | $0.00 | |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 16 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 32 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 24 | $0.00 |
| 0272 | 0% | 1,490 | $0.00 | |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 16 | $0.00 |
| 73070 | 0% | 29 | $0.00 | |
| 96417 | 0% | 52 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 25 | $0.00 |
| 99223 | Prolong inpt eval add15 m | 0% | 14 | $0.00 |
| L4387 | Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf | 0% | 28 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAYLOR, AMY (SR. DIRECTOR REIMBURSEMENT)
| Provider | Location | Paid |
|---|---|---|
| Mariposa Community Health Center, INC | Nogales, AZ | $67.95M |
| Mariposa Community Health Center, INC | Patagonia, AZ | $12.97M |
| Mariposa Community Health Center, INC | Rio Rico, AZ | $3.64M |
| Mariposa Community Health Center, INC | Nogales, AZ | $1.27M |
| Mariposa Community Health Center, INC | Nogales, AZ | $980K |
| Mariposa Community Health Center, INC | Tubac, AZ | $354K |
| Brewerton Volunteer Fire Department Ambulance INC | Brewerton, NY | $116K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.